Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose PPI for Post-sphincterotomy Bleeding
NCT01873079Phase 3Completed
- Sponsor
- The University of Hong Kong
- Start
- Apr 2013
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of esomeprazole (2 arms), sponsored by The University of Hong Kong. Primary endpoint: Proportion of patients with bleeding after sphincterotomy at 10 days. Started Apr 2013; status: completed.
02
Drugs
esomeprazole
Beyond the preview
Go deeper on NCT01873079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01873079.